Keyphrases
Multiple Sclerosis
100%
Parkinson's Disease
78%
Parkinson Patients
50%
Multiple Sclerosis Treatment
32%
Cerebrospinal Fluid
28%
Osteopontin
24%
Alzheimer's Disease
20%
Neurodegenerative Diseases
19%
Amyotrophic Lateral Sclerosis
19%
Polymorphism
16%
T Cells
16%
Nave
14%
Disability
13%
Unified Parkinson's Disease Rating Scale (UPDRS)
12%
Cognitive Impairment
12%
Autoimmune Disease
12%
Potential Biomarkers
12%
Cognitive Decline
12%
CD4+ T Cells
11%
Chronic Inflammatory Demyelinating Polyneuropathy
11%
Disease Progression
11%
Healthy Controls
10%
Transcription Factor
10%
Multiple Sclerosis Diagnosis
10%
Working Diagnosis
10%
CD4+ T
10%
Neurodegeneration
10%
T Cell Apoptosis
9%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
9%
Safinamide
9%
Kappa Free Light Chains
9%
Neuroinflammation
9%
Immune Response
8%
Immune System
8%
Peripheral Neuropathy
8%
Patients with Parkinson's Disease
8%
Optic Neuritis
8%
Motor Evoked Potential
8%
Autoimmune
8%
Intrathecal Synthesis
8%
Extracellular Vesicles
8%
Rehabilitation Therapy
8%
Progranulin mutation
8%
Single nucleotide Polymorphism
8%
Experimental Autoimmune Encephalomyelitis
7%
Italy
7%
Mild Cognitive Impairment
7%
Dyskinesia
7%
Disease Course
7%
Levodopa
7%
Neuroscience
Multiple Sclerosis
98%
Parkinson's Disease
91%
T Cell
37%
Osteopontin
23%
Alzheimer's Disease
20%
CD4
16%
Neurodegenerative Disorder
13%
Neuropathy
13%
Intrathecal
12%
Stereotypic Movement Disorder
12%
Ultrasonography
11%
Cognitive Disorders
11%
Dopamine Receptor
11%
Dopaminergic
11%
Polyneuropathy
11%
Amyotrophic Lateral Sclerosis
10%
Lymphocyte
10%
Haplotype
10%
Progranulin
10%
Mild Cognitive Impairment
9%
L-DOPA
9%
Light Chain
9%
Comorbidity
9%
Safinamide
9%
Transcranial Magnetic Stimulation
8%
Optic Nerve
8%
Motor Evoked Potential
8%
In Vitro
7%
Optic Neuritis
7%
Programmed Cell Death
7%
Transcription Factors
7%
Receptor Gene
7%
Growth Disorder
7%
Neurodegeneration
6%
Antiphospholipid Syndrome
6%
Immune System Disorders
6%
Central Nervous System
6%
Parkinsonism
6%
Single-Nucleotide Polymorphism
6%
Human Immunodeficiency Virus
6%
Relapsing Remitting Multiple Sclerosis
5%
Experimental Autoimmune Encephalomyelitis
5%
Proteasome
5%
Expanded Disability Status Scale
5%
Variable Number Tandem Repeat
5%
Information Processing
5%
Immunoglobulin G
5%
Blood Plasma
5%
Medicine and Dentistry
Parkinson's Disease
40%
Multiple Sclerosis
32%
Biological Marker
17%
T Cell
13%
Diseases
12%
Stereotypic Movement Disorder
9%
T Lymphocyte
9%
Light Chain
8%
Amyotrophic Lateral Sclerosis
8%
T-Helper Cell
8%
COVID-19
8%
Transcription Factors
7%
Programmed Cell Death
6%
Chronic Inflammatory Demyelinating Polyneuropathy
6%
Safinamide
6%
Antiphospholipid Syndrome
6%
Echography
6%
Cerebrospinal Fluid
6%
Adverse Event
5%
Cognitive Defect
5%
Hepatitis C Virus
5%
Degenerative Disease
5%
Vascular Endothelial Cell
5%
